The present disclosure relates generally to the field of respiratory therapy and more particularly to the application of respiratory therapies.
Sleep apnea occurs when a person stops breathing during sleep. An apnea may generally be defined as the cessation of airflow for a period of time, e.g., more than 10 seconds. Apneas may lead to decreased blood oxygenation and thus, to the disruption of sleep. With some apneas, e.g., central apnea, the subject's airway is open however, the subject is not attempting to breathe. Conversely, with other apneas, the airway is closed, The airway may also be partially obstructed (i.e., narrowed). This also leads to decreased ventilation, decreased blood oxygenation, and/or disturbed sleep.
A common form of treatment for apnea is the administration of Continuous Positive Airway Pressure (hereinafter “CPAP”). Effective CPAP treatment may act as a pneumatic splint of the airway by the provision of a constant positive pressure usually in the pressure range of about 4 to about 20 cmH2O. Another form of treatment for apnea, is the administration of bi-level treatment. With bi-level treatment, one constant pressure level is provided during inhalation and a second constant pressure level, generally a lower pressure level, is provided during exhalation. With both treatments, increased pressure is supplied to the airway of the subject by a motor driven blower whose outlet supplies air via a delivery hose and mask to the subject's airway, e.g., via the subject's nose, mouth, or both (nose and mouth). An exhaust port may be provided in the mask and/or the delivery tube proximate the mask. The mask may take the form of a nose, mouth and/or face mask or nasal prongs, pillows or cannulae.
In many cases, subjects who experience sleep apnea also experience a significant narrowing of the upper airways during the latter part or period of exhalation and in the upper airways at the end of exhalation. In addition, airway occlusion or narrowing at the end of exhalation often precedes an apneic event and airway resistance during exhalation also increases prior to apneic events. As a result, ordinary CPAP therapy may make it difficult for a subject to exhale because the exhalation is resisted by a continuous positive pressure of air. Current treatments for this problem include monitoring a subject's airflow and adjusting the applied pressure breath-by-breath so that a variable pressure is applied to a subject during exhalation. The pressure that is applied during exhalation is lower than the CPAP pressure and varies on a breath-by-breath basis depending on the subject's airflow. Under current treatments, the pressure forms a reverse bell curve, where the applied pressure is gradually lowered when exhalation begins, reaches a minimum point at the middle of exhalation, and then is raised gradually so that the CPAP level is reached when inhalation begins. Although this treatment lowers the applied pressure resisting a subject's exhalation, exhalation by a subject during the first part of exhalation may still be more difficult than necessary. This is because the decrease in the applied pressure during exhalation under current treatments is gradual and the subject must exhale against a pressure that is higher that the minimum pressure point that will be applied during all but an instantaneous moment of exhalation.
In accordance with the present disclosure, systems and methods for detecting respiratory events and applying improved respiratory therapies are provided. According to one embodiment, a method for delivering pressurized gas to an airway of a subject is disclosed. The method may include applying a constant pressure at a level, e.g., a predetermined level, less than an effective pressure, e.g., therapeutic pressure, at approximately the beginning of exhalation until approximately the nadir of exhalation, raising the applied pressure to an effective pressure at rate, e.g., a predetermined rate, beginning at or approximately at the nadir of exhalation until the beginning or until approximately the beginning of inhalation, and applying pressure at an effective pressure during inhalation.
According to another embodiment, a system for delivering pressurized gas to an airway of a subject is disclosed. The system may include a gas source, e.g. a blower, a flow sensor connected for monitoring, preferably continuously monitoring, e.g., via a pilot tube or via any other methodology, a respiratory flow rate from the subject, a low pass filter operable to generate at least one of and preferably both a filtered flow and a dynamic flow from the respiratory flow rate, a pressure controller connected to the gas source, e.g., a gas generator, operable to control pressure levels applied from the gas source, and an event detection device, e.g., an event detector, connected to the pressure controller wherein the event detection device is preferably operable to: detect the beginning of exhalation in the subject, provide a signal to the pressure controller to apply a constant pressure at a level, e.g., a predetermined level, less than an effective or therapeutic pressure, detect the nadir or approximately the nadir of exhalation in the subject; send a signal to the pressure controller to raise the applied pressure to an effective pressure at a rate, e.g., a predetermined rate; detect approximately the beginning or the beginning of inhalation; and send a signal to the pressure controller to apply pressure at an effective pressure.
According to another embodiment, a computer-readable storage medium containing a set of instructions executable on a processor is disclosed. The set of instructions may include a routine operable to monitor, e.g., continuously, a respiratory flow rate from a subject, and a routine operable to control a motor, blower, or pump connected to apply a constant pressure at a level, preferably a predetermined level less than an effective pressure at the beginning or approximately the beginning of exhalation until the nadir (or approximately the nadir) of exhalation; raise the applied pressure to an effective pressure, e.g., a therapeutic pressure, at a rate, preferably a predetermined rate beginning at or about the nadir of exhalation until at or about the beginning of inhalation; and apply pressure at an effective or therapeutic pressure during inhalation.
According to another embodiment, a system for delivering pressurized gas to an airway of a subject is disclosed. The system may include a gas source means operable to deliver pressurized gas to the subject, a flow sensing means operable to continuously monitor a respiratory flow rate from the subject, a low pass filter means operable to generate at least one of and preferably both of a filtered flow and a dynamic flow from the respiratory flow rate, a pressure controller means connected to the gas source operable to control pressure levels applied from the gas source, and an event detection means connected to the pressure controller means wherein the event detection means may be operable to: detect the beginning or the approximate beginning of exhalation in the subject, send a signal to the pressure controller means to apply a constant pressure at a level, e.g., a predetermined level, less than an effective pressure, detect the nadir (or an approximate nadir) of exhalation in the subject, send a signal to the pressure controller means to raise the applied pressure to an effective pressure, e.g., a therapeutic pressure at a rate, e.g., a predetermined rate, detect the beginning or approximate beginning of inhalation; and send a signal to the pressure controller means to supply an effective or therapeutic pressure.
Some embodiments of the disclosure may be understood by referring, in part, to the following description and the accompanying drawings, in which like reference numbers refer to the same or like parts, and wherein:
Selected embodiments of the disclosure may be understood by reference, in part, to
In general, the present disclosure describes methods and apparatuses for applying positive pressure respiratory therapy and for decreasing and maintaining a low and fixed applied pressure level during a first part or first period of exhalation. The near immediate application of a relief pressure, preferably a fixed relief pressure value at or during the beginning of exhalation, as opposed to the gradual application of a reduction in pressure, offers more immediate improvement to a subject's ability to exhale and reduces the likelihood of the occurrence of an apneic event. According to one example of the present disclosure, instead of applying respiratory therapy by gradually lowering and raising the pressure between exhalation and inhalation, the apparatus of
The apparatus of
In the apparatus of
For example, in the event a subject's effective pressure is determined to be eight cmH2O and the predetermined pressure level is determined to be three cmH2O, a fixed relief pressure value of five cmH2O may be applied to the subject via mask 110 and gas source 150 from nearly the beginning of exhalation 210 until the nadir or approximately the nadir of exhalation 230, as determined by event detection device 140. Once a subject has reached the nadir or approximately the nadir of exhalation 230, the pressure applied to the subject may be raised at a rate, e.g., preferably a predetermined rate such that the effective pressure may be reached when the subject begins the inhalation phase of breathing at step 250. The predetermined rate may preferably be proportional to the subject's flow rate. The steps of
According to an embodiment of the present disclosure, an effective pressure level 321 is applied to a subject during inhalation. This pressure can be delivered through mask 110 and provided by gas source 150 controlled by pressure controller 160. This higher positive pressure level may improve the ability of the subject to inhale. This effective pressure level is shown at point 321 in the lower graph. As inhalation is about to end at point 311, a relief pressure 322, e.g., a fixed value relief pressure, is applied from the beginning of exhalation until the nadir of exhalation 313. The near immediate application of a fixed relief pressure 322 value during exhalation, as opposed to the gradual application of a reduced pressure, offers a more immediate improvement to a subject's ability to exhale and reduces the likelihood of the occurrence of an apneic event. In a short time period before inhalation ends, the pressure applied to the subject is reduced as instantaneously as possible to a relief pressure, e.g., a relief pressure value 322. The effective pressure 321 begins to drop in a short time period near the end of inhalation 311 so that the relief pressure may be applied immediately or as soon as possible when exhalation begins This short period before inhalation ends represents the amount of time for the breathing device to lower the pressure to a relief pressure, e.g., to pressure value 322. This period may be less than three hundred milliseconds when an effective pressure is ten cmH2O and a predetermined pressure level is 3 cmH20. A relief pressure, e.g., relief pressure value 322, may be a fixed pressure value and may be applied to the subject until the nadir or peak of exhalation 313. The near immediate application of a relief pressure value, according to this example a fixed pressure, during exhalation, as opposed to a gradual application of a relief pressure, offers more immediate improvement to a subject's ability to exhale. After the nadir of exhalation 313, the applied pressure may be raised at a rate, e.g., a predetermined rate 323, such that an effective pressure may be reached when inhalation begins. This treatment may be applied throughout a subject's breathing.
Numerous other changes, substitutions, variations, alterations, and modifications may be ascertained to one skilled in the art and it is intended that the present invention encompass all such changes, substitutions, variations, alterations, and modifications as falling within the scope of the appended claims.
This application claims priority from U.S. Provisional Application No. 61/018,126, filed, Dec. 31, 2007, which is hereby incorporated by reference herein in its entirety.
Number | Date | Country | |
---|---|---|---|
61018126 | Dec 2007 | US |